Changing distribution of Candida species isolated from sterile and nonsterile sites in Israel

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 21, Issue 7, 2002, Pages 542-545

  Samra, Z ^a,c   Bishara, J ^a   Ashkenazi, S ^b   Pitlik, S ^a   Weinberger, M ^a   Lapidoth, M ^a   Yardeni, M ^a   Levy, I ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; FUNGUS ISOLATION; HUMAN; ISRAEL; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

CANDIDA; CANDIDIASIS; CARRIER STATE; HUMANS; ISRAEL; PREVALENCE; STERILIZATION;

EID: 0036042529     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0764-7     Document Type: Article

References (16)

1. National epidemiology of mycoses survey (NEMIS): Variation in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
2. Prevalence of antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: Results of a two-year (1996-1998) multicenter surveillance study in Quebec, Canada
3. Systemic Candida infection in university hospital, 1997-1999: The distribution of Candida biotypes and antifungal susceptibility patterns
4. Trends in species distribution and susceptibility to fluconazole among bloodstream isolates of Candida species in the United States
5. Nosocomial candidemia with species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution
6. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
7. Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidemia cases over a 5-year period
8. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period
9. In vitro susceptibility of 545 isolates of Candida species to four antifungal agents
10. Effects of fluconazole administration in critically ill patients: Analysis of bacterial and fungal resistance
11. National surveillance of nosocomial bloodstream infection due to species of Candida other than Candida albicans: Frequency of occurrence of antifungal susceptibility in the SCOPE program
12. International surveillance of bloodstream infection due to Candida species in European SENTRY program: Species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
13. National epidemiology of mycoses survey: A multicenter study of strain variation and antifungal susceptibility among isolates of Candida species
14. International surveillance of bloodstream infection and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada and South America for the SENTRY program
15. Dynamics of Candida isolation from humans for 1992-1995 in Greifswald, Germany
16. Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility